Further to the inititive and support from a Director of the Genetic Resources Institute (GRI) of the Azerbaijan National Academy of Sciences (ANAS), Corresponding Member of ANAS Dr. Zeynal Akperov, masters and doctorates, as well as engaged in the research work Azerbaijani scientists, who obtained education in Biology, Medicine and Agriculture in foreign universities and scientific centers, present their reports at webinars in the GRI and discuss the cooperation prospects.
To this end, Allahverdi Shaveranov, who obtained his doctorate education in the Peoples’s Republic of China made a presentation entitled “Cancer stem cells in brain tumors” at the webinar in GRI.
During the presentation he provided general information about the brain tumors and stem cells. The topic on the cancer stem cells in brain tumors, especially in the Glioblastoma multiforme (GBM) type was discussed. The presentation followed by a question and answer session, as well as proposals from the participants of the vebinar.
Shaveranov pointed out that after completion of his doctorate education he would return to Azerbaijan and would hold joint researches on the genetics of brain tumors via using opportinities available at the GRI.
Employees of the GRI, the Azerbaijan State Medical University, the Baku State University and doctor of science in Biology, who held the research work at the King Abdullah University of Science & Technology in Saudi Arabia, Corresponding Member of the ANAS Ilham Shakhmuradov attended the scientific seminars.
After graduation from the Faculty of treatment-prevention from the Azerbaijan State Medical University Allahverdi Shaveranov continued education on doctorate level in Medicine in Tongji Cancer Center in the People’s Republic of China in 2007-2015 within the State Program on Education Abroad of the Ministry of Education of Azerbaijan Republic.
During the term of study he published articles on molecular biology of cancer and Neuroscience. One of the articles, namely “Isoflurane enhances the malignant potential of glioblastoma stem cells by promoting their viability, mobility in vitro and migratory capacity in vivo” was published in the “British Journal of Anaesthesia” publication (Impact Factor of 4.85) of the Oxford University Press.
The research work was implemented jointly by employees working in the Stanford University School of Medicine and Johns Hopkins Hospital entering the list of the Top Medical Centers in the world.
He published an article entitled “Interleukin-6: an emerging regulator of pathological pain” jointly with employees of the cancer center who work in the “Journal of Neuroinflammation” (Impact Factor of 5.4) on the 7 June 2016.
The list of international articles of the young researcher is below as follows:
- Han, N., Shahveranov, A., Cheng, Y., Qin, K., Yu, S. Y., & Zhang, M. X. (2014). Effects of connective tissue growth factor (CTGF) gene silencing on the radiosensitivity of glioblastoma. Int J Clin Exp Med, 7(9), 2557-2563.
- M. Zhu, M. Li, Y. Zhou, S. Dangelmajer, U. D. Kahlert, R. Xie, Q. Xi, A. Shahveranov, D. Ye, and T. Lei, “Isoflurane enhances the malignant potential of glioblastoma stem cells by promoting their viability, mobility in vitro and migratory capacity in vivo” Br. J. Anaesth. (2016) 116 (6): 870-877. doi: 10.1093/bja/aew124
- Ya-Qun Zhou, Zheng Liu, Zhi-Heng Liu, Shu-Ping Chen, Man Li, Allahverdi Shahveranov, Da-Wei Ye and Yu-Ke Tian, “Interleukin-6: an emerging regulator of pathological pain” Journal of Neuroinflammation 201613:141. doi: 10.1186/s12974-016-0607-6